Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer

Tundra lists 1 Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT05458674

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

The purpose of this study is to evaluate the safety and efficacy of the three-drug combination of tucatinib, trastuzumab, and eribulin in patients with de novo and recurrent unresectable metastatic HER-2/neu positive breast cancer as assessed by ORR, PFS and OS after prior treatment with a taxane, trastuzumab, and T-DM1.

Gender: All

Ages: 18 Years - Any

Updated: 2026-04-03

5 states

Breast Cancer

Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer